Experience

Stibbe advises on the equity offering of ProQR

Stibbe advises on the equity offering of ProQR

Stibbe advises on the equity offering of ProQR

10.09.2018 NL law

Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). 

ProQR is a biopharmaceutical company creating transformative RNA medicines for the treatment of severe genetic rare diseases and listed on Nasdaq.

Team

Related experience

Our website uses cookies: third party analytics cookies to best adapt our website to your needs & cookies to enable social media functionalities. For more information on the use of cookies, please check our Privacy and Cookie Policy. Please note that you can change your cookie opt-ins at any time via your browser settings.

Privacy – en cookieverklaring